BB
BB Biotech Portfolio holdings
AUM
$3.98B
This Quarter Return
+31.67%
1 Year Return
+15.06%
3 Year Return
+120.36%
5 Year Return
+263.74%
10 Year Return
–
AUM
$3.09B
AUM Growth
+$3.09B
(+26%)
Cap. Flow
+$55.2M
Cap. Flow
% of AUM
1.79%
Top 10 Holdings %
Top 10 Hldgs %
71.33%
Holding
29
New
3
Increased
10
Reduced
10
Closed
1
Top Buys
| 1 |
PTC Therapeutics
PTCT
|
$63.6M |
| 2 |
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
|
$51.7M |
| 3 |
CEMP
Cempra, Inc.
CEMP
|
$18.2M |
| 4 |
Gilead Sciences
GILD
|
$14.1M |
| 5 |
Puma Biotechnology
PBYI
|
$8.52M |
Top Sells
| 1 |
Ionis Pharmaceuticals
IONS
|
$40.7M |
| 2 |
CELG
Celgene Corp
CELG
|
$19.6M |
| 3 |
Incyte
INCY
|
$18.3M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$14.4M |
| 5 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$10.2M |
Sector Composition
| 1 | Healthcare | 81.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
1
DELISTED
Celgene Corp
CELG
| $415M | 13.46% | 3,714,298 -175,000 | -4% | -$19.6M |
|
|
2
Ionis Pharmaceuticals
IONS
$6.79B
| $369M | 11.95% | 5,976,526 -660,000 | -10% | -$40.7M |
|
|
3
Incyte
INCY
$16.5B
| $296M | 9.59% | 4,051,867 -250,000 | -6% | -$18.3M |
|
|
4
Gilead Sciences
GILD
$140B
| $278M | 8.99% | 2,945,596 +150,000 | +5% | +$14.1M |
|
5
Agios Pharmaceuticals
AGIO
$2.19B
| $209M | 6.77% | 1,864,921 -25,600 | -1% | -$2.87M |
|
6
Vertex Pharmaceuticals
VRTX
$100B
| $161M | 5.21% | 1,354,445 | – | – |
|
|
MDVN
7
DELISTED
MEDIVATION, INC.
MDVN
| $138M | 4.47% | 1,384,706 -45,000 | -3% | -$4.48M |
|
|
ALXN
8
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $124M | 4.03% | 672,428 -55,000 | -8% | -$10.2M |
|
|
RDUS
9
DELISTED
Radius Health, Inc.
RDUS
| $107M | 3.47% | 2,752,140 +7,100 | +0.3% | +$276K |
|
|
GEVA
10
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $105M | 3.4% | 1,130,476 +37,000 | +3% | +$3.43M |
|
|
11
Puma Biotechnology
PBYI
$254M
| $98.8M | 3.2% | 521,991 +45,000 | +9% | +$8.52M |
|
|
PCYC
12
DELISTED
PHARMACYCLICS INC
PCYC
| $89.4M | 2.9% | 731,542 | – | – |
|
|
13
Regeneron Pharmaceuticals
REGN
$61.5B
| $81.2M | 2.63% | 198,000 -35,000 | -15% | -$14.4M |
|
|
RCPT
14
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $79.8M | 2.58% | 651,181 +14,408 | +2% | +$1.77M |
|
15
Alnylam Pharmaceuticals
ALNY
$58.5B
| $72.9M | 2.36% | 751,288 -30,000 | -4% | -$2.91M |
|
16
Neurocrine Biosciences
NBIX
$13.8B
| $69M | 2.23% | 3,086,552 -30,000 | -1% | -$670K |
|
17
Halozyme
HALO
$8.56B
| $65.9M | 2.13% | 6,825,532 +395,000 | +6% | +$3.81M |
|
|
18
PTC Therapeutics
PTCT
$3.92B
| $63.6M | 2.06% | +1,227,912 | New | +$63.6M |
|
|
TTPH
19
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $51.7M | 1.67% | +1,302,114 | New | +$51.7M |
|
20
Novavax
NVAX
$1.21B
| $46.8M | 1.52% | 7,900,000 +400,000 | +5% | +$2.37M |
|
|
INFI
21
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $39.2M | 1.27% | 2,320,737 | – | – |
|
|
CLVS
22
DELISTED
Clovis Oncology, Inc.
CLVS
| $34.6M | 1.12% | 618,188 +60,000 | +11% | +$3.36M |
|
|
TSRO
23
DELISTED
TESARO, Inc.
TSRO
| $26.2M | 0.85% | 704,582 | – | – |
|
|
IMGN
24
DELISTED
Immunogen Inc
IMGN
| $19.8M | 0.64% | 3,240,816 +75,000 | +2% | +$458K |
|
|
CEMP
25
DELISTED
Cempra, Inc.
CEMP
| $18.2M | 0.59% | +775,000 | New | +$18.2M |
|